PubMed ID:
18040661
Public Release Type:
Journal
Publication Year: 2008
Affiliation: Department of Clinical Biochemistry, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK. Eric.Kilpatrick@hey.nhs.uk
DOI:
https://doi.org/10.1007/s00125-007-0883-x
Authors:
Atkin SL,
Kilpatrick ES,
Rigby AS
Studies:
Diabetes Control and Complications Trial
It is not known whether mean blood glucose (MBG) predicts the risk of macrovascular complications in diabetes any differently from HbA1c. In this study we therefore analysed data from the Diabetes Control and Complications Trial (DCCT) to assess the relationship between MBG, HbA1c and glucose variability with regard to the risk of cardiovascular disease in patients with type 1 diabetes.